Ludek Pour
AuthID: R-00H-BBQ
1
TITLE: Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial Full Text
AUTHORS: Knop, S; Mateos, MV; Dimopoulos, MA; Suzuki, K; Jakubowiak, A; Doyen, C; Lucio, P; Nagy, Z; Usenko, G; Pour, L; Cook, M; Grosicki, S; Crepaldi, A; Liberati, AM; Campbell, P; Shelekhova, T; Yoon, SS; Losava, G; Fujisaki, T; Garg, M; ...More
PUBLISHED: 2021, SOURCE: BMC CANCER, VOLUME: 21, ISSUE: 1
AUTHORS: Knop, S; Mateos, MV; Dimopoulos, MA; Suzuki, K; Jakubowiak, A; Doyen, C; Lucio, P; Nagy, Z; Usenko, G; Pour, L; Cook, M; Grosicki, S; Crepaldi, A; Liberati, AM; Campbell, P; Shelekhova, T; Yoon, SS; Losava, G; Fujisaki, T; Garg, M; ...More
PUBLISHED: 2021, SOURCE: BMC CANCER, VOLUME: 21, ISSUE: 1
INDEXED IN: 
Scopus 
WOS
Scopus WOS2
TITLE: Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial Full Text
AUTHORS: Maria Victoria Mateos; Michele Cavo; Joan Blade; Meletios A Dimopoulos; Kenshi Suzuki; Andrzej Jakubowiak; Stefan Knop; Chantal Doyen; Paulo Lucio; Zsolt Nagy; Ludek Pour; Mark Cook; Sebastian Grosicki; Andre Crepaldi; Anna Marina Liberati; Philip Campbell; Tatiana Shelekhova; Sung Soo Yoon; Genadi Iosava; Tomoaki Fujisaki; ...More
PUBLISHED: 2020, SOURCE: LANCET, VOLUME: 395, ISSUE: 10218
AUTHORS: Maria Victoria Mateos; Michele Cavo; Joan Blade; Meletios A Dimopoulos; Kenshi Suzuki; Andrzej Jakubowiak; Stefan Knop; Chantal Doyen; Paulo Lucio; Zsolt Nagy; Ludek Pour; Mark Cook; Sebastian Grosicki; Andre Crepaldi; Anna Marina Liberati; Philip Campbell; Tatiana Shelekhova; Sung Soo Yoon; Genadi Iosava; Tomoaki Fujisaki; ...More
PUBLISHED: 2020, SOURCE: LANCET, VOLUME: 395, ISSUE: 10218
INDEXED IN: WOS
WOS3
TITLE: Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
AUTHORS: Michele Cavo; Francesca Gay; Meral Beksac; Lucia Pantani; Maria Teresa Petrucci; Meletios A Dimopoulos; Luca Dozza; Bronno van der Holt; Sonja Zweegman; Stefania Oliva; Vincent H J van der Velden; Elena Zamagni; Giuseppe A Palumbo; Francesca Patriarca; Vittorio Montefusco; Monica Galli; Vladimir Maisnar; Barbara Gamberi; Markus Hansson; Angelo Belotti; ...More
PUBLISHED: 2020, SOURCE: LANCET HAEMATOLOGY, VOLUME: 7, ISSUE: 6
AUTHORS: Michele Cavo; Francesca Gay; Meral Beksac; Lucia Pantani; Maria Teresa Petrucci; Meletios A Dimopoulos; Luca Dozza; Bronno van der Holt; Sonja Zweegman; Stefania Oliva; Vincent H J van der Velden; Elena Zamagni; Giuseppe A Palumbo; Francesca Patriarca; Vittorio Montefusco; Monica Galli; Vladimir Maisnar; Barbara Gamberi; Markus Hansson; Angelo Belotti; ...More
PUBLISHED: 2020, SOURCE: LANCET HAEMATOLOGY, VOLUME: 7, ISSUE: 6
INDEXED IN: Scopus WOS
Scopus WOS4
TITLE: Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1 Full Text
AUTHORS: Maria Victoria Mateos; Tamas Masszi; Norbert Grzasko; Markus Hansson; Irwindeep Sandhu; Ludek Pour; Luisa Viterbo; Sharon R Jackson; Anne Marie Stoppa; Peter Gimsing; Mehdi Hamadani; Gabriela Borsaru; Deborah Berg; Jianchang C Lin; Alessandra Di Bacco; Helgi van de Velde; Paul G Richardson; Philippe Moreau;
PUBLISHED: 2017, SOURCE: HAEMATOLOGICA, VOLUME: 102, ISSUE: 10
AUTHORS: Maria Victoria Mateos; Tamas Masszi; Norbert Grzasko; Markus Hansson; Irwindeep Sandhu; Ludek Pour; Luisa Viterbo; Sharon R Jackson; Anne Marie Stoppa; Peter Gimsing; Mehdi Hamadani; Gabriela Borsaru; Deborah Berg; Jianchang C Lin; Alessandra Di Bacco; Helgi van de Velde; Paul G Richardson; Philippe Moreau;
PUBLISHED: 2017, SOURCE: HAEMATOLOGICA, VOLUME: 102, ISSUE: 10
INDEXED IN: Scopus WOS
Scopus WOS5
TITLE: Efficacy and safety of ixazomib plus lenalidomidedexamethasone (IRd) vs placebo-rd in patients (pts) with relapsed/refractory multiple myeloma (RRMM) by cytogenetic risk status in the global phase III Tourmaline-MM1 study.
AUTHORS: Paul G Richardson; Herve Avet Loiseau; Antonio Palumbo; Luisa Viterbo; Arnon Nagler; Peter Ganly; Dina Ben Yehuda; Jesus San Miguel; Vincent V Rajkumar; Ludek Pour; Christian Langer; Nizar J Bahlis; Andrzej Pluta; Tamas Masszi; Deborah Berg; Jianchang C Lin; Helgi Van De Velde; Dixie Lee Esseltine; Alessandra di Baccot; Philippe Moreau;
PUBLISHED: 2016, SOURCE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, ISSUE: 15
AUTHORS: Paul G Richardson; Herve Avet Loiseau; Antonio Palumbo; Luisa Viterbo; Arnon Nagler; Peter Ganly; Dina Ben Yehuda; Jesus San Miguel; Vincent V Rajkumar; Ludek Pour; Christian Langer; Nizar J Bahlis; Andrzej Pluta; Tamas Masszi; Deborah Berg; Jianchang C Lin; Helgi Van De Velde; Dixie Lee Esseltine; Alessandra di Baccot; Philippe Moreau;
PUBLISHED: 2016, SOURCE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, ISSUE: 15
INDEXED IN: WOS
WOS